← Catalyst calendarGNPX biotech catalysts & pipeline
GENPREX INC · Data as of 2026-10-25
Upcoming catalysts
REQORSA and Tecentriq — Interim data
Late 2026
We expect to complete enrollment of the first 25 patients for interim analysis in the Phase 2 expansion portion of the study by the end of 2026 and expect the interim analysis in the first half of 2027.
Source filingREQORSA and Tecentriq — Interim data
H1 2027
We expect to complete enrollment of the first 25 patients for interim analysis in the Phase 2 expansion portion of the study by the end of 2026 and expect the interim analysis in the first half of 2027.
Source filingExplore the free biotech catalyst calendar
